                         SEQUENCE LISTING

<110>  PRESIDENT AND FELLOWS OF HARVARD COLLEGE
       Verdine, Gregory L
       Kennedy, Eileen J
 
<120>  LIGATION OF STAPLED POLYPEPTIDES

<130>  H0824.70023WO00

<150>  US 61/082935
<151>  2008-07-23

<150>  US 61/225191
<151>  2009-07-13

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  112
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic Peptide, human IL-13

<400>  1

Gly Pro Val Pro Pro Ser Thr Ala Leu Arg Glu Leu Ile Glu Glu Leu 
1               5                   10                  15      


Val Asn Ile Thr Gln Asn Gln Lys Ala Pro Leu Cys Asn Gly Ser Met 
            20                  25                  30          


Val Trp Ser Ile Asn Leu Thr Ala Gly Met Tyr Cys Ala Ala Leu Glu 
        35                  40                  45              


Ser Leu Ile Asn Val Ser Gly Cys Ser Ala Ile Glu Lys Thr Gln Arg 
    50                  55                  60                  


Met Leu Ser Gly Phe Cys Pro His Lys Val Ser Ala Gly Gln Phe Ser 
65                  70                  75                  80  


Ser Leu His Val Arg Asp Thr Lys Ile Glu Val Ala Gln Phe Val Lys 
                85                  90                  95      


Asp Leu Leu Leu His Leu Lys Lys Leu Phe Arg Glu Gly Arg Phe Asn 
            100                 105                 110         


<210>  2
<211>  12
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic Peptide, basic DNA binding region of Max with mutation sites at positions 2, 6, and 10

<400>  2

Arg Ala His His Asn Ala Leu Glu Arg Lys Arg Arg 
1               5                   10          


<210>  3
<211>  22
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic Peptide, IL-13 Helix-A, containing S5 at positions 6 and 10 for peptide stapling


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X = S5, (S)-2-amino-2-methylhept-6-enoic acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X = S5, (S)-2-amino-2-methylhept-6-enoic acid

<400>  3

Ser Thr Ala Leu Arg Xaa Leu Ile Glu Xaa Leu Val Asn Ile Thr Gln 
1               5                   10                  15      


Asn Gln Lys Ala Ala Leu 
            20          


<210>  4
<211>  22
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide, IL-13 Helix-A 

<400>  4

Ser Thr Ala Leu Arg Glu Leu Ile Glu Glu Leu Val Asn Ile Thr Gln 
1               5                   10                  15      


Asn Gln Lys Ala Pro Leu 
            20          


<210>  5
<211>  20
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide, IL-13 Helix-A 

<400>  5

Ala Leu Arg Glu Leu Ile Glu Glu Leu Val Asn Ile Thr Gln Asn Gln 
1               5                   10                  15      


Lys Ala Pro Leu 
            20  


<210>  6
<211>  24
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide, c-Myc bHLH region (residues 369-419), containing non-natural amino acids for peptide stapling


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X = non-natural amino acid

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X = non-natural amino acid

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  X = non-natural amino acid

<400>  6

Cys Val Gln Ala Glu Glu Gln Lys Leu Xaa Ser Glu Glu Xaa Leu Leu 
1               5                   10                  15      


Arg Xaa Arg Arg Glu Gln Leu Lys 
            20                  


<210>  7
<211>  24
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide, c-Myc bHLH region (residues 369-419), containing non-natural amino acids for peptide stapling


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X = non-natural amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X = non-natural amino acid

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X = non-natural amino acid

<400>  7

Cys Val Gln Ala Glu Xaa Gln Lys Leu Xaa Ser Glu Glu Xaa Leu Leu 
1               5                   10                  15      


Arg Lys Arg Arg Glu Gln Leu Lys 
            20                  


<210>  8
<211>  24
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide, c-Myc bHLH region (residues 369-419), containing non-natural amino acids for peptide stapling


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X = non-natural amino acid

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  X = non-natural amino acid

<400>  8

Cys Val Gln Ala Glu Glu Gln Lys Leu Ile Ser Glu Glu Xaa Leu Leu 
1               5                   10                  15      


Arg Xaa Arg Arg Glu Gln Leu Lys 
            20                  


